Patents by Inventor George Jarvis

George Jarvis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160178594
    Abstract: An analyzer system for sensing a chemical characteristic of a fluid sample according to one embodiment includes a sample inlet configured to receive the sample via the sample inlet, a reagent inlet configured to receive a reagent via the reagent inlet, a reaction zone in fluid communication with the sample inlet and the reagent inlet and being configured to receive the sample from the sample inlet and the reagent from the reagent inlet for mixing the sample with the reagent; and a sensor zone in fluid communication with the reaction zone, wherein the sensor zone comprises a sensor configured to sense the chemical characteristic of the mixed sample and reagent, and further wherein the sensor zone is configured to allow automatic drainage of the mixed sample and reagent away from the sensor after the sensor has sensed the chemical characteristic of the mixed sample and reagent.
    Type: Application
    Filed: December 23, 2015
    Publication date: June 23, 2016
    Inventors: George Jarvis, Victor Chung, Dave Balise, Edward Somes
  • Patent number: 8371296
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Grant
    Filed: May 8, 2006
    Date of Patent: February 12, 2013
    Assignee: Geno, LLC
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Publication number: 20120204659
    Abstract: In one aspect, an apparatus includes a head configured to receive a pad for sampling explosive residue on a surface and a feedback system coupled to the head. The feedback system is configured to indicate when a pressure applied by the head is greater than a minimum threshold value. In another aspect, an apparatus includes a head configured to receive a pad and rotate to apply a shear force to the pad for sampling explosive residue on a surface. The apparatus includes a feedback system coupled to the head, which is configured to restrict the shear force applied by the head to be within a predetermined range. In another aspect, a method includes applying pressure to a pad to sample explosive residue on a surface, sensing the pressure applied to the pad, and providing an indication of when the pressure applied to the pad is greater than a threshold value.
    Type: Application
    Filed: September 2, 2011
    Publication date: August 16, 2012
    Applicant: L-3 COMMUNICATIONS CYTERRA CORPORATION
    Inventors: David H. Fine, Ravi K. Konduri, Freeman W. Fraim, George Jarvis
  • Patent number: 8221800
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Grant
    Filed: April 7, 2006
    Date of Patent: July 17, 2012
    Assignee: Geno LLC
    Inventors: David H. Fine, Stephen J. MacDonald, David R. Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Patent number: 8066904
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Grant
    Filed: August 28, 2002
    Date of Patent: November 29, 2011
    Assignee: Geno LLC
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Patent number: 8011258
    Abstract: In one aspect, an apparatus includes a head configured to receive a pad for sampling explosive residue on a surface and a feedback system coupled to the head. The feedback system is configured to indicate when a pressure applied by the head is greater than a minimum threshold value. In another aspect, an apparatus includes a head configured to receive a pad and rotate to apply a shear force to the pad for sampling explosive residue on a surface. The apparatus includes a feedback system coupled to the head, which is configured to restrict the shear force applied by the head to be within a predetermined range. In another aspect, a method includes applying pressure to a pad to sample explosive residue on a surface, sensing the pressure applied to the pad, and providing an indication of when the pressure applied to the pad is greater than a threshold value.
    Type: Grant
    Filed: August 30, 2004
    Date of Patent: September 6, 2011
    Assignee: L-3 Communications CyTerra Corporation
    Inventors: David H. Fine, Ravi K. Konduri, Freeman W. Fraim, George Jarvis
  • Publication number: 20070089739
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Application
    Filed: May 8, 2006
    Publication date: April 26, 2007
    Applicant: GENO LLC
    Inventors: David Fine, Stephen MacDonald, David Rounbehler, David Wheeler, Jonathan Rolfe, George Jarvis
  • Publication number: 20060172018
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Application
    Filed: April 7, 2006
    Publication date: August 3, 2006
    Applicant: GENO LLC
    Inventors: David Fine, Stephen MacDonald, David Rounbehler, David Wheeler, Jonathan Rolfe, George Jarvis
  • Patent number: 7040313
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Grant
    Filed: August 28, 2002
    Date of Patent: May 9, 2006
    Assignee: CyTerra Corporation
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Patent number: 7025869
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Grant
    Filed: August 28, 2002
    Date of Patent: April 11, 2006
    Assignee: CyTerra Corporation
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Publication number: 20050081655
    Abstract: In one aspect, an apparatus includes a head configured to receive a pad for sampling explosive residue on a surface and a feedback system coupled to the head. The feedback system is configured to indicate when a pressure applied by the head is greater than a minimum threshold value. In another aspect, an apparatus includes a head configured to receive a pad and rotate to apply a shear force to the pad for sampling explosive residue on a surface. The apparatus includes a feedback system coupled to the head, which is configured to restrict the shear force applied by the head to be within a predetermined range. In another aspect, a method includes applying pressure to a pad to sample explosive residue on a surface, sensing the pressure applied to the pad, and providing an indication of when the pressure applied to the pad is greater than a threshold value.
    Type: Application
    Filed: August 30, 2004
    Publication date: April 21, 2005
    Inventors: David Fine, Ravi Konduri, Freeman Fraim, George Jarvis
  • Patent number: 6758214
    Abstract: A nitric oxide delivery system for delivering nitric oxide to a patient to treat a medical condition includes a container, a nitric oxide generation chamber, and a pump. The container is designed to contain a nitrogen-containing compound. The nitric oxide generation chamber includes a heat source and is designed to generate nitric oxide from the nitrogen-containing compound. The pump is designed to transfer at least a part of the nitrogen-containing compound from the container to the nitric oxide generation chamber.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: July 6, 2004
    Assignee: CyTerra Corporation
    Inventors: David H. Fine, Freeman W. Fraim, George Jarvis
  • Publication number: 20030064115
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Application
    Filed: August 28, 2002
    Publication date: April 3, 2003
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Publication number: 20030064028
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Application
    Filed: August 28, 2002
    Publication date: April 3, 2003
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Publication number: 20030062043
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Application
    Filed: August 28, 2002
    Publication date: April 3, 2003
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Publication number: 20010037810
    Abstract: A nitric oxide delivery system for delivering nitric oxide to a patient to treat a medical condition includes a container, a nitric oxide generation chamber, and a pump. The container is designed to contain a nitrogen-containing compound. The nitric oxide generation chamber includes a heat source and is designed to generate nitric oxide from the nitrogen-containing compound. The pump is designed to transfer at least a part of the nitrogen-containing compound from the container to the nitric oxide generation chamber..
    Type: Application
    Filed: January 26, 2001
    Publication date: November 8, 2001
    Inventors: David H. Fine, Freeman W. Fraim, George Jarvis